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Abstract: Recently, there has been an increase in the use of over-the-counter (OTC) drugs. The
consumption of these medicines can be unsafe, as incorrect self-diagnosis or the ingestion of in-
appropriate doses can lead to side effects and the occurrence of adverse reactions and drug–drug
interactions. A cross-sectional descriptive observational study was carried out, targeting the entire
Spanish population by using an online questionnaire. The results showed that 78.9% of the subjects
had previously taken or were currently taking OTC drugs. This consumption decreased as the age of
the subjects increased, with a prevalence of 36.4% of subjects aged ≥ 71 taking OTC drugs. Anal-
gesics were the most consumed OTC drugs (49.1%) especially in women, youngsters with non-formal
educational qualifications, and individuals of a low–medium socioeconomic level residing in urban
areas. Measures should be implemented to optimize the safe use of OTC drugs in order to avoid the
occurrence of secondary events associated with the lack of knowledge related to their the usage.
Keywords: nonprescription drugs; OTC drugs; OTC medication; over-the-counter medicines; self-
care; self-medication
1. Introduction
Recently, an increase has been observed in the use of pharmaceutical drugs by the
general population [1]. However, this increase has not been associated with an improve-
ment in health. According to the World Health Organization (WHO), more than 50% of the
drugs consumed worldwide are prescribed or dispensed inappropriately and almost 50%
of patients use these drugs incorrectly, resulting in increased morbidity and mortality [2,3].
Several factors have influenced this increase, namely, increased age, higher access to
medication and increased self-diagnosis and treatment, which means the management
of own health through all available resources, individual and/or collective [4]. This
self-management of health encompasses the concept of self-medication, defined as the
selection and use of drugs by individuals and/or caregivers to treat self-recognized or
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self-diagnosed conditions or symptoms. This self-medication can be an unsafe practice [5]
due to inaccurate self-diagnosis or an inappropriate dosage intake that can result in side
effects, adverse reactions, and pharmacological interactions [4]. The rate of self-medication
has been reported to be up to 90% in developing countries. Improper self-medication
increases the costs associated with health care.
Studies have shown that many factors (cultural, political, and environmental) influ-
ence the practice of self-medication for the prevention or treatment of symptoms and
diseases [6]. The most common medical ailments for which self-medication is practiced
include headache, joint pain, fever, cold and cough, allergy, heartburn and diarrhoea [7].
Increased access to medicines without improved health literacy increases the risk of misuse.
Among the drugs used most frequently by the population, there are some that require
a prescription in order to be dispensed, as opposed to OTC drugs. Different countries have
seen an increase in the consumption of OTC drugs, which can lead to their misuse [8].
In Spain, the purchase of prescription drugs has decreased and the consumption of OTC
drugs has increased (Figure 1) [9,10]. In addition, periods of economic crisis lead to an
increase in the number of patients taking OTC drugs [11].
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(2003–2018) [10].
Easy access to some medicines, such as OTCs, has caused the population to self-
medicate, basing their decisions on previous prescriptions and on the advice of agents
outside the health system, namely, family, friends, online social networks, internet search
engines etc. [12,13]. In addition, mass media plays an important role, as it directly broad-
casts advertisements concerning OTC drugs.
The aim of our study was to learn about the consumption of OTC drugs, the type of
OTCs consumed, and the identification of the groups in the population that are at a higher
risk of OTC drug consumption.
2. Materials and Methods
2.1. Selection of Participants and Study Design
We conducted a cross-sectional descriptive observational study that targeted the
entire Spanish population. The population is composed of different demographic groups
according to age, sex, and other demographic factors. It is important to note that the
unemployment rate before the start of the study in Spain was 14.41%, influencing this rate
on the socio-economic level and consequently on the acquisition of prescribed medicines
(free of charge for unemployed) and OTC drugs.
To calculate the sample size, the data published by The National Statistical Institute
(INE) on the 1st of July 2019 were taken as the reference, which reflected that the Spanish
population comprised 47,100,936 inhabitants. Epidat 4.2 software (Galician Health Service,
Galicia, Spain)) was used to calculate the sample size. The calculation of the sample size
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was carried out with a 95% confidence level and 3% precision, and since the expected
proportion of change in the population was unknown, a 0.5 proportion was selected. The
sample size was 203 subjects.
2.2. Instruments and Variables
The study variable selected was the consumption of OTCs, as an affirmative or negative
answer. In addition, another study variable, type of OTCs consumed, was also recorded.
Several independent variables were selected, such as sociodemographic variables
(gender, age, education level, and place of residence), economic variables (employment
status and socioeconomic status), and health variables (presence of disease or illness and
the consumption of medication).
In addition, information was collected concerning resources used to search for infor-
mation on OTC drugs (television, internet, social networks, etc.) This last variable was
collected by means of close-ended questions.
A self-administered questionnaire was developed to collect information about the
different variables. The items included in the questionnaire are shown in the results tables.
2.3. Data Collection
Concerning the dissemination of the questionnaire, new communication technology
using the Google questionnaire platform was employed, and social platforms on Twitter,
Facebook, WhatsApp, and Instagram were used for the dissemination. The questionnaire
was administered between March and April 2020. In this period, there were pandemic-
related mobility restrictions in Spain (Lockdown COVID-19).
2.4. Statistical Analysis
The data obtained from the different variables were represented descriptively, by
frequency and percentage. Subsequently, using a Chi-square test, we studied whether there
were significant differences between the dependent variable and the independent variables,
accepting a confidence level of 95%.
In addition, a multivariate logistic regression model was performed with all indepen-
dent variables (gender, age, study level, employment status, socioeconomic status and
place of residence) and OTC consumption. The statistical analysis was carried out with the
R-Commander software version 2.7-1 (Hamilton, ON, Canadá).
3. Results
3.1. Participants and Sociodemographic and Economic Variables
A total of 728 responses to the questionnaire were obtained. Of these, one response was
eliminated as it was incomplete, so the study was finally carried out using the remaining
727 responses.
Of the total sampled population under study, 75.1% were women (n = 546) and 24.9%
were men (n = 181). The age group representing the highest percentage in our study were
individuals aged 25 years (39.9%; n = 290), with ≥71 years of age being the group with the
lowest number of members (1.5%; n = 11).
The number of participants who had completed their education or were currently
studying at university level was 39.0% (n = 284), and only 3.1% (n = 23) did not possess
any educational qualifications. In addition, 43.2% (n = 314) were working at the time
of answering the questionnaire. A high percentage of subjects (60.8%) classified their
economic level as low–medium. Most participants (74.5%, n = 542) resided among an
urban population (Table 1).
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Table 1. Sociodemographic and economic variables of the total sampled population.
Variables N %
Gender:
• Female 546 75.1
• Male 181 24.9
Age:
• ≤25 years-old 290 39.9
• 26–40 years-old 169 23.3
• 41–55 years-old 203 27.9
• 56–70 years-old 54 7.4
• ≥71 years-old 11 1.5
Study level:
• No formal education 23 3.1
• Primary education 107 14.7
• Secondary education 50 6.9
• Vocational training 128 17.6
• Upper secondary education 90 12.4
• University degree 284 39.0
• Postgraduate degree 45 6.2
Employment status:
• Student 266 36.6
• Unemployed 115 15.8
• Employed 314 43.2
• Retired 32 4.4
Socioeconomic status:
• Low 79 10.9
• Low–medium 442 60.8
• Medium–high 198 27.2
• High 8 1.1
Place of residence:
• Rural 185 25.4
• Urban 542 74.5
Note: Results expressed as number of respondents (n) and percentage (%).
3.2. Health Status and Medication Use
In total, 59.0% (n = 429) of the sample did not present any type of condition or disease,
followed by 32.4% (n = 236) who reported a chronic condition (more than 6 months) and
8.5% (n = 62) who reported an acute condition (less than 6 months). In terms of gender,
women had more acute and chronic conditions than men (9.0% vs. 7.2%, and 34.1% vs.
27.6%, respectively), although there were no statistically significant differences (p = 0.148).
Chronic conditions were more prevalent in subjects with advanced age (71 years), who were
retired, and those residing among a rural population. In addition, women consumed more
medications than men (57.1% vs. 46.4%), which was mostly influenced by the following
factors, subjects aged between 56 and 70 years (83.3%), no formal education (69.6%), and
retirement (84.4%) (Table 2). Among the subjects taking medication, 61.6% (n = 244) were
taking medication prescribed by their doctor on a regular basis, while 28.4% (n =152) were
taking medication as needed, which had been previously prescribed or because they knew
of its benefits. In the last 6 months, 56.5% (n = 411) of the sampled population reported
taking medication sporadically, 35.7% (n = 260) took it regularly, and 7.7% (n = 56) did not
take any medication. Sporadic use was more prevalent in men (63.0%), adults (26–40 years:
66.3%), with postgraduate education (68.9%), individuals with a low economic status
(58.2%), students (66.9%), and those residing among an urban population (59.6%). Regular
consumption of drugs was more prevalent in women (39.2%), aged 56–70 years (70.4%),
with non-formal educational qualifications (56.5%), individuals with a high economic
status (62.5%), retired individuals (71.9%), and those residing among a rural population
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(41.7%). Statistically significant differences between the different categories of each variable
(p < 0.05) were confirmed.
Table 2. Health status and medication use of the population sample.
Do You Suffer from Any Condition? Are You on AnyMedication?
NO Acute Chronic p-Value YES NO p-Value
Gender:
0.148 0.011 *• Female 311 (57.0) 49 (9.0) 186 (34.1) 312 (57.1) 234 (42.9)
• Male 118 (65.2) 13 (7.2) 50 (27.6) 84 (46.4) 97 (53.6)
Age:
<0.001 *** <0.001 ***
• ≤25 years-old 191 (65.9) 28 (9.7) 71 (24.5) 123 (42.4) 167 (57.6)
• 26–40 years-old 113 (66.9) 17 (10.1) 39 (23.1) 78 (46.2) 91 (53.8)
• 41–55 years-old 103 (50.7) 13 (6.4) 87 (42.9) 141 (69.5) 62 (30.5)
• 56–70 years-old 20 (37.0) 3 (5.6) 31 (57.4) 45 (83.3) 9 (16.7)
• ≥71 years-old 2 (18.2) 1 (9.1) 8 (72.7) 9 (81.8) 2 (18.2)
Study level:
0.258 0.001 **
• Non-formal education 11 (47.8) 3 (13.0) 9 (39.1) 16 (69.6) 7 (30.4)
• Primary education 60 (56.1) 7 (6.5) 40 (37.4) 73 (68.2) 34 (31.8)
• Secondary education 28 (56.0) 8 (26.0) 14 (18.0) 32 (64.0) 18 (36.0)
• Vocational training 81 (63.3) 12 (9.4) 35 (27.3) 72 (56.2) 56 (43.8)
• Upper secondary education 44 (48.9) 9 (10.0) 37 (41.1) 47 (52.2) 43 (47.8)
• University degree 180 (63.4) 9 (6.7) 85 (29.9) 129 (45.4) 155 (54.6)
• Postgraduate degree 25 (55.6) 4 (8.9) 16 (35.6) 27 (60.0) 18 (40.0)
Employment status:
<0.001 *** <0.001 ***
• Student 178 (66.9) 24 (9.0) 64 (24.1) 112 (42.1) 154 (57.9)
• Unemployed 54 (47.0) 14 (12.2) 47 (40.9) 80 (69.6) 35 (30.4)
• Employed 186 (59.2) 23 (7.3) 105 (33.4) 177 (56.4) 137 (43.6)
• Retired 11 (34.4) 1 (3.1) 20 (62.5) 27 (84.4) 5 (15.6)
Socioeconomic status:
0.408 0.329
• Low 47 (59.5) 6 (7.6) 26 (32.9) 43 (54.6) 36 (45.6)
• Low–medium 255 (57.7) 43 (9.7) 144 (32.6) 248 (56.1) 194 (43.9)
• Medium–high 123 (62.1) 11 (5.6) 64 (32.3) 99 (50.0) 99 (50.0)
• High 4 (50.0) 2 (25.0) 2 (25.0) 6 (75.0) 2 (25.0)
Place of residence:
0.004 ** 0.080• Rural 93 (50.3) 14 (7.6) 78 (42.2) 111 (60.0) 74 (40.0)
• Urban 336 (62.0) 48 (8.9) 158 (29.2) 285 (52.6) 257 (47.4)
Note: Results expressed as number of respondents (percentage). Statistical significance * 0.05, ** 0.01; *** 0.001.
3.3. OTC Consumption
There were differences in the age groups, with the consumption of OTC drugs decreas-
ing with an increase in age. In total, 85.5% (n = 248) of subjects aged <25 years-old consume
or have consumed OTC drugs, decreasing this percentage to 36.4% (n = 4) in subjects aged
>71 years-old. Additionally, the subjects with graduate degrees consumed fewer OTC
drugs (n = 70; 65.4%) when compared to those with postgraduate degrees (n = 39; 86.7%).
Significant differences were also observed between different groups according to their
employment status. Retired subjects indicated a lower consumption of OTC drugs (n = 19;
59.4%). Students were among the groups that indicated the highest consumption of OTC
drugs (n = 222; 85.7%).
In addition, 72.6% (n = 528) responded that they had bought an OTC drug advertised
on television (Table 3).
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Table 3. Prevalence of OTC drugs use.
Variables YES (n, %) NO (n, %) p-Value
Gender:
0.984• Female 431 (78.9) 115 (21.1)
• Male 143 (79.0) 38 (21.0)
Age:
<0.001 ***
• ≤25 years-old 248 (85.5) 42 (14.5)
• 26–40 years-old 140 (82.8) 29 (17.2)
• 41–55 years-old 148 (72.9) 55 (27.1)
• 56–70 years-old 34 (63.0) 20 (37.0)
• ≥71 years-old 4 (36.4) 7 (63.6)
Study level:
0.001 **
• Non-formal education 19 (82.6) 4 (17.4)
• Primary education 70 (65.4) 37 (34.6)
• Secondary education 36 (72.0) 14 (28.0)
• Vocational training 104 (81.2) 24 (18.2)
• Upper secondary education 66 (73.3) 24 (26.7)
• University degree 240 (84.5) 44 (15.5)
• Postgraduate degree 39 (86.7) 6 (13.3)
Employment status:
<0.001 ***
• Student 228 (85.7) 38 (14.3)
• Unemployed 83 (72.2) 32 (27.8)
• Employed 244 (77.7) 70 (22.3)
• Retired 19 (59.4) 3 (40.6)
Socioeconomic status:
0.468
• Low 62 (78.5) 17 (21.5)
• Low–medium 342 (77.4) 100 (22.6)
• Medium–high 164 (82.8) 34 (17.2)
• High 6 (75.0) 2 (25.0)
Place of residence:
0.205• Rural 140 (75.7) 45 (24.3)
• Urban 434 (80.1) 108 (19.9)
Note: Results expressed as number of respondents (percentage). Statistical significance ** 0.01; *** 0.001.
3.4. Type of OTC Drugs Consumed
Analgesics were the most consumed OTC drugs (n = 357; 49.1%), while antidepres-
sants were the least commonly consumed OTC drugs (n = 3; 0.4%) (Figure 2). Although
antidepressants are not considered OTC, they have been included in this analysis, as they
are available from some online “pharmacies” and have sometimes also been purchased
from conventional pharmacies [14].
In terms of gender, women consumed more analgesics and cough medicine than men
(51.8% vs. 40.9%, and 16.7% vs. 14.4%, respectively). The rest of the drugs were consumed
more by men, and this difference was greater in the “other” group, which includes all drugs
not described above (difference of 7.9%). By age, young people (25 years of age) consumed
more analgesics, with the consumption of antihistamines, gastroprotection, and “other”
drugs increasing with age. Subjects without academic degrees consumed more analgesics
(69.6%) than the rest of the population. The consumption of medicines for the common cold
and antihistamines was higher in subjects with a higher level of education (postgraduates),
at 24.4% and 8.9%, respectively. Employment status also indicated differences among the
various groups, and the consumption of analgesics was more prevalent in students (55.6%).
Socioeconomic status was also another factor that influenced consumption of OTC drugs.
In this respect, significant associations were found between individual’s socioeconomic
status and their consumption of drugs such as antibiotics, antidepressants, common cold
drugs, and antihistamines (Table 4).
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Table 4. Major types of OTC drugs.
Variables
OTC Drugs (%)
AN ATB ATD CCD ATH CM GP MR OT p
Gender:
0.008 **• Female 51.8 2.4 0.4 12.6 5.5 16.7 3.1 2.7 4.8
• Male 40.9 2.8 0.6 13.8 5.0 14.4 4.4 5.5 12.7
Age:
<0.001 ***
• ≤25 years-old 53.4 4.1 0.0 6.6 5.2 17.6 2.4 2.4 8.3
• 26–40 years-old 49.7 3.6 0.0 18.9 4.7 11.2 2.4 5.3 4.1
• 41–55 years-old 44.3 0.0 1.0 18.2 6.4 15.8 4.4 4.4 5.4
• 56–70 years-old 42.6 0.0 1.9 9.3 3.7 27.8 7.4 0.0 7.4
• ≥71 years-old 45.5 0.0 0.0 9.1 9.1 0.0 9.1 0.0 27.3
Study level:
0.006 **
• Non-formal education 69.6 0.0 0.0 4.3 4.3 13.0 0.0 4.3 4.3
• Primary education 38.3 1.9 1.9 14.0 5.6 21.5 4.7 5.6 6.5
• Secondary education 38.0 6.0 0.0 18.0 6.0 18.0 2.0 6.0 6.0
• Vocational training 39.1 1.6 0.0 18.0 5.5 24.2 3.1 3.9 4.7
• Upper secondary education 53.3 3.3 0.0 10.0 6.7 14.4 6.7 0.0 5.6
• University degree 58.1 1.8 0.0 9.2 4.2 12.7 2.8 2.8 8.5
• Postgraduate degree 40.0 6.7 2.2 24.4 8.9 4.4 4.4 4.4 6.7
Employment status:
<0.001 ***
• Student 55.6 4.5 0.0 6.8 4.5 14.3 3.0 2.6 8.6
• Unemployed 45.2 1.7 0.9 13.0 3.5 27.0 5.2 2.6 0.9
• Employed 45.9 1.3 0.3 18.2 7.3 13.1 2.9 4.8 6.4
• Retired 40.6 0.0 3.1 12.5 0.0 21.9 0.2 0.0 15.6
Socioeconomic status:
<0.001 ***
• Low 43.0 7.6 00 15.2 3.8 19.0 1.3 3.8 6.3
• Low–medium 50.2 1.4 0.5 11.5 4.5 16.7 4.3 3.8 7.0
• Medium–high 49.0 2.0 0.0 15.7 8.1 13.6 2.5 2.5 6.6
• High 50.0 25.0 12.5 0.0 0.0 12.5 0.0 0.0 0.0
Place of residence:
0.574• Rural 45.4 2.7 0.0 11.9 8.1 17.8 2.7 3.8 7.6
• Urban 50.4 2.4 0.6 13.3 4.4 15.5 3.7 3.3 6.5
AN: Analgesics; ATB: Antibiotics; ATD: Antidepressants; CCD: Common cold drugs; ATH: Antihistamines; CM: Cough medicine; GP:
Gastroprotection; MR: Muscle relaxants; OT: Others. Statistical significance ** 0.001. *** 0.001.
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3.5. Self-Medication and Consumption of OTC Drugs
Questions related to the consumption of these medicines and self-medication were
asked. When subjects were asked what action they took when they had a headache 66.2%
(n = 481) responded that they self-medicated with an analgesic, 29.7% (n = 216) did not
take anything and waited for it to go away on its own, and 4.1% checked with friends and
family (1.1%; n = 8) or went to their doctor or pharmacist (3.0%; n = 22).
In addition, 14.7% (n = 107) responded that they took medication before experiencing
any symptoms, using it as prevention before the onset of symptoms.
3.6. Search for Information.
A total of 58.5% (n = 425) of subjects surveyed, reported that they had searched the
internet for information about medication. More specifically, 89.1% (n = 648) responded
that when they had a headache, they searched for information to know the cause and/or
the treatment. However, when they had doubts about a medication, 49.7% (n = 361) read
the package leaflet, followed by 35.9% (n = 261) who went to a healthcare professional or
pharmacist, 10.0% (n = 73) who searched the internet, and 4.4% (n = 32) who asked a family
member and/or a friend. As there was a high percentage of patients who consulted the
package leaflet, they were asked if they knew how to look for information in the leaflet
and if they were aware of the warning symbols. In total, 77.3% (n = 562) of those surveyed
knew how to look for information in the package leaflet.
3.7. OTC Drugs Odds Ratio and Independent Variables
After performing the multivariate regression model, the category “≥71 years” of the
variable age, and the groups “non-formal education” and “university” in the variable level
of studies presented statistical significances. Subjects aged ≥ 71 years are less likely to use
OTC drugs (OR = 0.04; CI: 0.00–0.27, p < 0.001). However, the category “no education” and
“university students” presented OR values of 4.23 (CI: 1.21–18.41, p = 0.033) and 1.84 (CI:
1.00–3.33, p = 0.045), respectively (Table 5).
Table 5. Odds Ratio Values.
Variables OR CI 95% p
Gender (Male)
• Female 1.05 0.66–1.63 0.830
Age (≤25 years-old)
• 26–40 years-old 0.80 0.38–1.64 0.550
• 41–55 years-old 0.59 0.26–1.25 0.179
• 56–70 years-old 0.26 0.09–0.68 0.006
• ≥71 years-old 0.04 0.00–0.27 <0.001 ***
Study level (Upper Secondary education)
• Non-formal education 4.23 1.21–18.41 0.033 *
• Primary education 0.58 0.49–1.94 0.963
• Secondary education 0.96 0.43–2.21 0.932
• Vocational training 1.62 0.82–3.10 0.162
• University degree 1.84 1.00–3.33 0.045 *
• Postgraduate degree 2.59 0.95–8.06 0.076
Employment Status (Unemployed)
• Student 1.20 0.52–2.67 0.654
• Employed 1.17 0.68–1.98 0.563
• Retired 1.82 0.58–6.12 0.311
Socioeconomic status (High)
• Low 1.12 0.13–6.58 0.899
• Low–medium 1.01 0.12–5.55 0.985
• Medium–high 1.34 0.15–7-73 0.753
Place of residence (Rural)
• Urban 1.79 0.76–1.79 0.448
OR: Odds Ratio; CI: Confidence Interval. Note: Statistical significance * 0.05, *** 0.001.
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4. Discussion
The results obtained show that the consumption of OTC drugs is high (78.9%), with
higher consumption in subjects aged ≤ 25 years (85.5%), students (85.7%) and those with
postgraduate degrees (86.7%). Of these medicines, analgesics are the most consumed
medicines (49.1%).
OTC drugs are relatively safe, however inappropriate use can lead to complications
and adverse events that affect public health [15]. Due to their greater availability and ease of
acquisition, these drugs are consumed before or at the onset of symptoms. The percentage
of consumption of OTC drugs obtained from our study results (78.9%) is higher than
that reported in other countries such as Turkey (33%) and lower than Sweden (87%) [16],
Czech Republic (92%), and Cyprus (97%) [17]. It is worth noting that almost six out of ten
respondents had no medical condition or illness at all, and only 8.5% had an acute illness.
The present study found that several items (aged ≤ 25 years (85.8%); students (85.7%);
postgraduate education (86.7%); medium-high economic status (82.8%); urban population
(80.1%)) were associated with a higher consumption of OTC drugs. These results are similar
to those obtained by other researchers, although in our study, differences with regard to
gender were not obtained [18]. In contrast to a previous study conducted by Shah et al.,
subjects aged >65 years-old were not the major consumers of OTC drugs in Spain [19].
This difference may be due to this population having greater contact with prescribers of
medicines and the fact that the medicines prescribed are free of charge. Subjects living
among rural populations indicated a lower consumption of OTC drugs than those residing
among urban populations. However, the consumption of drugs prescribed by medical
practitioners was higher, as well as the presence of chronic diseases. These results, although
at a lower percentage (23%), were similar to those obtained by Dutta et al. in a rural
population [20]. This may be due to different factors such as: the availability of these drugs
in pharmacies, the consumption of advertising through the media and social networks [21],
the greater presence of acute illness, lifestyle, and living in an urban population.
Our results show that the groups with opposite levels of education, namely, subjects
with no formal education qualifications and subjects pursuing university education were
among those most likely to consume OTC drugs, with a probability of 4.23 and 1.84 times
higher than the rest of the subjects, respectively. Conversely, in a previous study conducted
in Eritrea, respondents with elementary and non-formal education were fifteen times more
likely to consume OTC drugs compared to those with a higher education [15].
Pain relief is a prominent factor influencing the use of these drugs internationally,
with headaches, low back pain, and joint pain being the triggers leading to the use of
these drugs. Analgesics are the most frequently consumed OTC drugs [22]. Therefore,
analgesics constitute the largest OTC market worldwide [23]. The consumption of NSAIDs
in our study population was lower than that reported in other studies, such as the study
conducted by Arain et al. in 2019, where they concluded that 68.9% of the population
took OTC NSAIDs. In addition, analgesics can lead to side effects that affect the health
of the consumer. In the aforementioned study, one third of the population was unaware
of contraindications associated with analgesics [24]. After analgesics, antitussives and
common cold drugs were most commonly consumed by our subjects, which is different
to the results published by other authors, who reported that analgesics are the most
consumed, followed by antipyretics and antibiotics [25]. In addition, we recall again that
antidepressants are not considered as OTC medicines but are present in this study because
of their possible acquisition without prescription in some cases. Hence, the number of
subjects who have taken this medicine without a prescription is very low (n = 3).
Another important aspect is the presentation of OTC drugs and the information
contained in the product. In this respect, the package leaflet played a fundamental role,
as it provided the user with essential information about the drug. A total of 49.7% of the
participants in our study reported that they read the package leaflet when they had doubts
about a drug, but only 77.3% knew how to properly look for information in the leaflet
and understand the warning symbols. These results were different from those obtained in
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previous studies, which concluded that 59.6% read the package leaflets regularly, although
more than half of the leaflets (57.4%) had legibility problems [26].
Direct-consumer advertising by the pharmaceutical industry is important, especially
in relation to OTC drugs. This type of advertising is done through advertisements on TV,
radio, and other sources [27]. Our results showed that 27.4% had consumed an OTC drug
advertised on TV. In addition, many consumers use the internet to search for information
concerning the use of OTC drugs or products. A total of 58.5% of the respondents reported
that they used the internet to search for information about drugs, reflecting the importance
of e-health literacy [28].
The low representativeness of the older population (≥56 years) and of male subjects
are two of the study’s limitations. This may be due to the use of an online questionnaire,
as opposed to a face-to-face interview, but it was a strategy used to overcome restrictions
and avoid contact during the COVID-19 pandemic. The use of online questionnaires as a
method of survey collection during the pandemic has increased exponentially. This study
did not ask about the frequency or use of different medications as this was not the main
objective of the study (i.e., this study aimed to focus on the consumption and type of
OTC drugs and at-risk population consuming these medicines) but this may be seen as a
study limitation.
5. Conclusions
The consumption of OTC drugs in the study population is very high, much higher
than the prevalence of acute or chronic diseases and the consumption of prescription drugs
in this population. Subjects with a non-formal education or a university education are the
population groups that are most likely to consume OTC drugs.
Among OTC drugs, analgesics are the most consumed, followed by antitussives, and
drugs for the common cold.
National health policies concerning the use of OTC drugs should be targeted at these
populations and drug groups in order to optimize their use and avoid the occurrence of side
effects associated with the lack of knowledge in the use of these drugs. In addition, these
policies should improve e-health literacy, considering the increase in the number of people
who use the internet or social networks as health resources to search for information.
Further research in this area should be carried out, covering a sample of the
older population.
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